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BACKGROUND: The WASF3 protein is involved in cell movement and invasion, and to investigate its role in prostate cancer progression
we studied the phenotypic effects of knockdown in primary tumors and cell lines.
METHODS: ShRNA was used to knockdown WASF3 function in prostate cell lines. Cell motility (scratch wound assay), anchorage
independent growth and in vivo tumorigenicity and metastasis were then compared between knockdown and wild-type cells.
RESULTS: Increased levels of expression were seen in high-grade human prostate cancer and in the PC3 and DU145 cell lines.
Inactivation of WASF3 using shRNAs reduced cell motility and invasion in these cells and reduced anchorage independent growth
in vitro. The loss of motility was accompanied by an associated increase in stress fiber formation and focal adhesions. When
injected subcutaneously into severe combined immunodeficiency (SCID) mice, tumor formation was significantly reduced for PC3
and DU145 cells with WASF3 knockdown and in vivo metastasis assays using tail vain injection showed a significant reduction for
PC3 and DU145 cells. The loss of the invasion phenotype was accompanied by down-regulation of matrix metalloproteinase 9.
CONCLUSIONS: Overall, these observations demonstrate a critical role for WASF3 in the progression of prostate cancer and identify
a potential target to control tumorigenicity and metastasis.
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Metastasis is the primary cause of cancer death, and recent studies
have shown that cancer progression to metastasis is controlled
by specific genes, many of which are independent of the primary
oncogenic transforming events. In this category of genes, some
are related to metastasis suppression (Shevde and Welch, 2003;
Steeg, 2003) and others are related to the promotion of metastasis
(Sossey-Alaoui et al, 2007). We recently identified the WASF3/
WAVE3 gene at a chromosome translocation breakpoint involving
the 13q12 region through a positional cloning strategy (Sossey-
Alaoui et al, 2002) and subsequently showed that it is involved
in the regulation of cell movement and invasion (Sossey-Alaoui
et al, 2007) that was correlated with reduced lamellipodia
formation at their leading edge (Sossey-Alaoui et al, 2005a,b).
As a result, in vitro invasion potential of these cells was drastically
reduced.
The WASF3 gene (Sossey-Alaoui et al, 2003) is a member of the
Wiskott Aldrich syndrome family of proteins (WASP), which carry
verprolin-cofilin-acidic domains at their C-terminal ends. These
domains are thought to coordinate the recruitment of monomeric
actin and the ARP2/3 complex of proteins to facilitate actin
polymerization, which is essential for cell movement and invasion
(Albiges-Rizo et al, 2009). Phosphorylation of WASP proteins has
been shown to regulate their activity (Cory et al, 2002; Suetsugu
et al, 2002; Torres and Rosen, 2003; Wu et al, 2004; Park et al,
2005) and enhances actin polymerization (Yokoyama et al, 2005).
WASF2 was shown to be phosphorylated by the ABL kinase, which
stimulated cell spreading and invasion (Stuart et al, 2006) and we
recently showed that the same was true for WASF3 (Sossey-Alaoui
and Li, 2007). Recently, WASF3 has been shown to localize
to dendritic spines and constitutive activation of RAC resulted in
translocation of WASF3 to the leading edges of lamellipodia
guiding morphological plasticity of neurons (Pilpel and Segal,
2005).
During our overall survey of WASF3 expression in tumor
cells, high levels were noted in prostate cancer cells and we
now demonstrate that cells from high-grade tumors show
increased WASF3 expression. We, therefore, initiated a series of
experiments to analyze the role of WASF3 expression in prostate
cancer metastasis. In this study we have demonstrated that
transcriptionally stable knockdown of WASF3 in PC3 and DU145
cells using shRNA resulted in the inhibition of in vitro invasive-
ness and anchorage independent cell growth. Furthermore,
knockdown of WASF3 significantly reduced xenograft tumor
growth and metastasis in vivo. Thus, it appears that increased
WASF3 expression could have a more general role in promoting
metastasis in a variety of cancers that overexpress it, and so
may be a valuable biomarker to predict tumor progression, as
well as presenting a potential target, to prevent invasion and
metastasis.
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Cell culture
Human PC3 and DU145 cell lines (American Type Tissue
Collection) were cultured in RPMI-1640, supplemented with 10%
fetal bovine serum (FBS, Hyclone, Logan, UT, USA), 10Uml
 1
penicillin, and 10Uml
 1 streptomycin, at 371C in a humidified
atmosphere containing 5% CO2.
Retroviral vectors and transduction
The pSM2 retroviral vector containing a short hairpin RNA against
WASF3 (Catalog no. RHS1764-9702604) was obtained from Open
Biosystems (Huntsville, AL, USA). The Phoenix gag-pol only
packaging cell line (ATCC) was transiently transfected with
plasmid DNA using Effectene reagent (Qiagen, Valencia, CA,
USA). The virus-containing supernatants were collected and
filtered 48, 60, and 72h after transfection and then used to infect
PC3 and DU145 cell lines at least three times in the presence of
polybrene (4mgml
 1, Sigma, St. Louis, MO, USA) and selected
with 1.2mgml
 1 puromycin (Sigma), respectively. Individual
clones were obtained by ring-cloning and propagated in puromy-
cin-containing media. To rescue WASF3 expression, full length of
WASF3, lacking the 30-untranslated region (UTR), was cloned into
pCDNA3.1. WASF3-knockdown cells were transfected with either
the empty pCDNA vector or pCDNA–WASF3 (pCDNA-W3).
Following selection with G418, a mock population and WASF3-
expressing stable cells were generated.
Semi-Quantitative Reverse Transcription–PCR (RT–PCR)
and Quantitative RT-PCR (qRT–PCR)
Total RNA was extracted using TRIzol (Invitrogen, Carlsbad, CA,
USA) according to the manufacturer’s instructions. To remove
residual DNA, total RNA samples were treated with DNase I
(Invitrogen). First-strand cDNA was synthesized using SuperScript
II RT–PCR kit (Invitrogen) with 1mg of RNA. RT–PCR was
performed using 1ml cDNA template to amplify the target genes
with the following primers: WASF3 forward 50-TGCCTTTAGTGA
AGAGGAACA-30; WASF3 reverse 50-CAGCCCATCCTTCTTGTC
AT-30; WASF3 30UTR forward 50-CTTCAGCGTCTTTTCCTAGA-30;
WASF3 30UTR reverse 50-CAGGCTCATGAATATTTATG-30; matrix
metalloproteinase (MMP)-2 forward 50-AGCTTTGACGATGACCG
CAAATGG-30, MMP-2 reverse 50-GCCAATGGCTTGTCTGTTGGT
TCT-30; MMP-9 forward 50-GAGGTTGACGTGAAGGCGCAGTG-30,
MMP-9 reverse 50-ATAGCAGCTGCCTCAGTACT-30; b-actin forward
50-CCTCGCCTTTGCCGATCC-30; b-actin reverse 50-GGATCTTCATG
AGGTAGTC-30. RT–PCR was performed using a BioRad iCycler
(Bio-Rad, Foster City, CA, USA) using BioRad iQ SYBR Green
Supermix (Bio-Rad) with primers for WASF3 and GAPDH, respec-
tively. Primers for human WASF3 were obtained from SABiosciences
(Frederick, MD, USA) and primers for GAPDH were forward 50-AAT
CCCATCACCATCTTCCA-30 and reverse 50-TGGACTCCACGACGTA
CTCA-30. Experiments were performed independently at least three
times and each sample was analyzed in triplicate. Gene expression
levels were normalized against GAPDH.
Immunoblot analysis
Cells were lysed in ice-cold RIPA buffer (25mM Tris-HCl, pH 7.5,
150mM NaCl, 1mM EDTA, 1% Triton X-100, and a mixture
of proteases inhibitors) and analyzed by SDS–PAGE followed
by immunoblotting. Briefly, after blocking with 5% milk, the
membranes were probed with primary antibodies at 41C overnight.
The membrane was washed and then incubated with secondary
antibodies at room temperature for 1h. Immunoreactive proteins
were developed with enhanced chemiluminescence reagents
(Pierce, Rockford, IL, USA). The following antibodies were used:
rabbit anti-WASF3 (1:500, Cell Signaling, Danvers, MA, USA),
mouse anti-b-actin (1:3000, Sigma). Horseradish peroxidase-
conjugated anti-mouse and anti-rabbit were used as secondary
antibodies (Pierce).
Cell proliferation analysis
Cell proliferation activity was determined using the MTT method
(4,5-dimethyl-thiazol-2yl)-2,5-difenyltetrazolium bromide). Cells
were plated into 96-well plates at 3 10
3 cells per well and
cultured in 5% FBS growth media for various durations. At each
end time point cells were treated with MTT (5mgml
 1; Sigma) and
incubated at 371C and after 3h the MTT solution was discarded
and the wells were refilled with 200ml dimethyl sulfoxide. After
mixing, the OD 560 value for each well was measured using
a microplate reader (Bio-Rad).
Wound-closure assays
DU145 cells were seeded into 6-well plates at 1 10
5 per well.
Confluent monolayers were starved overnight and a single scratch
wound was created by dragging a 10ml plastic pipette tip across the
cell surface. Cells were washed with phosphate-buffered saline
(PBS) once to remove cell debris and supplemented with RPMI
culture media containing 2% FBS. The area of a defined region
within the scratch was measured using ImageJ software at time¼0
and again after 24h. The extent to which the wound had closed
over 24h was calculated and expressed as a percentage of the
difference between times 0 and 24h.
Soft agar assays
Cells were seeded into 6-well plates using a two-layer soft agar
system as described previously (Kunapuli et al, 2003; Sun et al,
2008). After 14 days incubation, colonies were stained with MTT
for 30min, and then the size and number of colonies was
determined. All the experiments were repeated independently at
least three times using triplicate plates.
Matrigel invasion assay
Matrigel invasion assays were performed as described previously
(Kunapuli et al, 2003). Briefly, transwells (BD biosciences, San Jose,
CA, USA) with 8-mm pore size filters covered with matrigel were
inserted into 24-well plates. RPMI (500ml) containing 10% FBS was
added to the lower chamber, and 200ml of a serum-free cell
suspension (5 10
4 cells) was placed in the upper chamber. The
plates were incubated at 371Cw i t h5 %C O 2 for 24 or 36h. After
several rinses, the cells in the lower chamber were fixed in methanol
and stained with 0.2% Crystal violet. Numbers of the invasive cells in
nine randomly selected fields from triplicate chambers were counted
in each experiment under a phase-contrast microscope.
Animal experiments
Male 6- to 8-week-old mice were purchased from National Cancer
Institute (NCI). Exponentially growing PC3 cells (2 10
6 cells per
flank) or DU145 cells (1 10
6 cells per flank) were suspended in
100ml of serum-free RPMI per 100ml Matrigel (BD Biosciences)
and injected subcutaneously into both flanks of SCID mice. First
week after injection, the growth of primary tumors was monitored
twice a week by measuring tumor diameters with calipers and
calculating tumor volume (mm
3) using the standard formula:
V¼(LþW
2)/2, where L is the length and W is the width of a
xenograft. Xenograft tumors were harvested at varying times after
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were used for cell culture or for isolation of total RNA or protein.
All animal experiments were approved by the MCG Animal Care
and Use Committee.
To determine metastasis to the lung, 1 10
6 PC3 or DU145 cells
were injected into 6- to 8-week-old male SCID mice through the
tail vein, respectively. Mice were killed 3 months after injection
and the lungs were stained with 10% Indian ink through tracheal
injection as described previously (Sossey-Alaoui et al, 2007). The
lungs were then fixed in 10% neutral buffered formalin, embedded
in paraffin blocks, sectioned at 5mm, and subjected hematoxylin
and eosin staining.
Immunofluorescence microscopy
DU145 cells were fixed with 3.7% formaldehyde in PBS for 15min
and permeabilized with 0.1% Triton X-100 in PBS for 10min. After
blocking for 1h, the cells were incubated with anti-vinculin
(Sigma) overnight at 41C, followed by incubation for 1h with
fluorescein isothiocyanate goat anti-mouse IgG and Texas-red
phalloidin (Molecular Probes, Eugene, OR, USA). Coverslips were
mounted with Vectashield mounting medium (Vector Labo-
ratories, Burlingame, CA, USA) containing nuclear stain
40, 6-diamidino-2-phenylindole and then visualized using a Zeiss
LSM 410 confocal microscope equipped with  63 (1.4 numerical
aperture) oil objectives (Carl Zeiss, Jena, Germany). Cells were
scored positive for intensive stress fibers when bundles of actin
filaments were seen clearly emerging from the central portion of
the cell. In all quantifications, only those cells presenting with free
borders were considered, and at least 100 cells from randomly
selected fields were evaluated.
Immunohistochemistry
Tumors and tissues were recovered by surgery and embedded in
paraffin by routine diagnostic procedures. Paraffin sections were
cut at 5mm, placed on charged slides and dried in a 601C oven for
1h. Room temperature slides were deparaffinized in three changes
of Xylene and rehydrated using graded alcohols. Endogenous
peroxidase was quenched with aqueous 3% H2O2 for 10min and
washed with PBS/T. Antigen retrieval was then performed using
citrate buffer pH 6 in the microwave for 10min, and allowed to
cool for 15min followed by a PBS/T wash. The slides were then
placed on the DAKO (Carpinteria, CA, USA) autostainer and the
following program was run: PBS/T wash followed by a 30min
incubation in 0.03% casein in PBS/T, and an 1h incubation at
room temperature with 0.5mgml
 1 of rabbit anti-WAVE3 (New
England Peptide, Gardner, MA, USA). Rabbit IgG at 0.5mgml
 1
was used on a duplicate slide in place of the primary antibody as a
negative control. A PBS/T wash was followed by biotinylated
secondary goat anti-rabbit antibody for 30min. A PBS/T wash
was followed by the ABC reagent (Vector labs) for 30min. Slides
were washed in PBS/T and the chromogen 3, 30-diaminobenzidine
(DAKO) was applied for 5min (color reaction product – brown).
The slides were then counterstained with Hematoxylin, dehy-
drated, cleared, and coverslipped.
Pro- and active MMP9 detection
PC3 or DU145 cells (1 10
5) were seeded in 12-well plates and
grown to 70–80% confluency in 1ml of DMEM with 2% FBS. After
24h, the media were collected in tubes and centrifuged for 10min
at 10000g. The pro- and active MMP-9 levels released into the
media were measured using a Fluorokine MAP human MMP9
kit (R&D Systems, Minneapolis, MN, USA) according to the
manufacturer’s instructions. The fluorescent signal in the sample
was determined using a BioRad analyzer at excitation/emission
wavelengths of 340nm per 465nm.
Statistical analysis
Where indicated, the results were representative of at least three
independent experiments performed in triplicate and were
expressed as the mean±s.d. Different values among groups were
compared using the Student’s t-test. For analysis of the in vivo
metastasis data, statistical significance of the total number of
tumors observed in DU145 experimental and control groups was
assessed using a statistical test based on the Poisson model, which
assumes that the number of tumors in a mouse is a Poisson
random variate. This model is appropriate when small numbers of
mice are present in both groups (Edgington, 1995). Under this
model, and the null hypothesis of no difference across conditions,
all Poisson variates in both groups have the same parameter. The
difference between total number of tumors in control and
experimental groups is; sum (control)-sum (test), which is a
difference of two independent Poisson variates with parameters
2*mu and 4*mu following the so-called Skellam distribution
(Karlis and Ntzoufras, 2006). As the value of mu may be computed
from the data, the appropriate P-value can be obtained from
Skellam distribution tables. For the analysis of PC3 experimental
and control groups we used a standard permutation test
(Edgington, 1995) to assess the significance of the observed
number of tumors in the experimental group.
RESULTS
High expression of WASF3 in primary prostate cancer
A survey of prostate cancer cell lines using qRT–PCR demon-
strated that PC3 and DU145 cells (Figure 1) expressed readily
detectable levels of WASF3, which correlated with protein levels as
assessed using western blotting. Immunohistochemical analysis of
high-grade human prostate cancer demonstrated increased levels
of WASF3 compared with normal prostate epithelium (Figure 2).
Thus, to investigate the consequences of inactivation of WASF3 in
these prostate cancer cell lines, we created stable clones from PC3
and DU145 cells carrying shRNAs targeting WASF3.
Knockdown of WASF3 in prostate cancer cells
PC3 and DU145 cells were transfected with shRNAs targeting the
WASF3 gene. Individual antibiotic-resistant clones were selected
and analyzed for mRNA levels using RT–PCR and qRT–PCR. In
the overall experiment, there was considerable variation in the
level of the mRNA knockdown between clones, but several of them
were shown to exhibit a high degree (490%) of knockdown, which
on western blotting showed a corresponding loss of protein
(Figure 1). In addition, individual antibiotic-resistant clones from
both cell lines were also identified that showed only marginal
knockdown of expression and protein levels (Figure 1). These
clones were used as additional controls in the biological assays
described below.
Growth rates of these various clones were investigated using the
MTT assay. No major difference in growth rates were seen in a
comparison between PC3 or DU145 clones that showed high-level
knockdown and clones that showed only marginal knockdown
(data not shown).
Loss of WASF3 expression results in reduced in vitro
invasion and motility
WASF3, and its family members, are involved in actin cytoskeleton
reorganization and high level expression has been associated with
invasion in breast cancer cells (Sossey-Alaoui et al, 2005a). To
evaluate the consequences of loss of WASF3 protein expression in
prostate cancer cells, we subjected them to matrigel invasion
assays. The PC3 parental cells are highly invasive in this assay and
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the knockdown cells (Figure 3) clearly showed a significantly
reduced invasion potential. The invasion potential for clone 19,
which did not show knockdown of WASF3, was similar to the
parental cells. DU145 cells showing 490% knockdown similarly
showed a significant reduction in invasion potential, compared
with cells that did not (Figure 3).
The scratch wound assay has also been used to characterize
cell motility, which is another phenotype related to invasion.
Unfortunately, the PC3 cells used in these studies have a rounded
morphology and these cells tend to pile up in the dish rather
than spreading out. As such, it was not possible to critically
assess motility using the wound closure assay for these cells.
DU145 cells, on the other hand, attach to the surface of the
culture dish and spread out, allowing easy visualization of motility.
When DU145 clone 4, which shows limited knockdown of WASF3,
was compared with clones 8 and 14, which show extensive
knockdown, a clear reduction in wound-healing capability was
noted in the knockdown cells (Figure 3), further supporting the
relationship between WASF3 expression and cell motility in
prostate cancer cells.
These in vitro data clearly demonstrate that WASF3 can
influence phenotypes related to tumor motility and invasion,
suggesting that it may influence prostate cancer cell metastasis.
Loss of WASF3 is associated with reduced anchorage
independent growth
One of the hallmarks of malignant cells is their ability to grow
under anchorage independent conditions. This phenotype is
typically analyzed in vitro using soft agar clonogenic assays. To
evaluate the role of WASF3 in anchorage independent growth, we
seeded prostate cancer cells in soft agar and evaluated colony size
and number (Figure 4). Parental PC3 cells form large colonies in
soft agar with high efficiency, and WASF3-expressing PC3 clone 19
showed almost the same ability as the parental cells to grow in soft
agar (Figure 4). In contrast, three knockdown clones, 13, 21, and
31, showed a significant reduction in colony number and size
(Figure 4). In DU145 cells the same trend was observed. WASF3-
expressing clone 4 was highly efficient in establishing clones in soft
agar, whereas knockdown clones 8 and 14 were not. These data
suggested that WASF3 might also have a significant role in tumor
establishment.
*
Figure 2 Immunohistochemical analysis of WAVE3 expression in
prostate cancer. High levels of WASF3 in poorly differentiated
prostatic adenocarcinoma (arrows) compared with minimal expression in
normal prostatic ducts (*). (DAB immunohistochemistry;  20 original
magnification).
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Figure 1 shRNA knockdown of WASF3 expression. (A) RT–PCR analysis of WASF3 mRNA expression shows high levels in parental (control) PC3 and
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sLoss of WASF3 is associated with reduced tumorigenicity
in vivo
The in vitro analyses described above suggested that WASF3 can
influence tumorigenicity and invasion of prostate cancer cells. To
determine whether the same is true in vivo,2 10
6 cells from the
shRNA knockdown clones 13 and 31 from PC3 were injected into
the flanks of SCID mice (five animals per experimental group) in
parallel with clone 19 that showed no knockdown of WASF3.
Tumor development in control and knockdown cells was measured
at regular intervals using calipers to assess tumor volume. In these
studies, tumors from clone 19 developed rapidly reaching
41500mm
2 within three weeks (Figure 5A). In contrast, the
two knockdown clones showed a significant reduction in tumor
growth rate. In addition, analysis of the final tumor weights after
3 weeks demonstrated an overall significant reduction in the size
of these tumors. Analysis of WASF3 protein levels in the resultant
tumors demonstrated the maintenance of a significant reduction
in WASF3 expression (Figure 5). Western blot analysis for WASF3
protein in representative tumors from clones 19 and 31
demonstrates that the protein levels in these tumors were similar
to those seen in the implanted cells. When cells from these
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stumors were reintroduced into culture, and similarly analyzed,
sustained knockdown of WASF3 was confirmed (data not
shown).
When DU145 cells were analyzed for tumorigenicity in
subcutaneous injections into both flanks of SCID mice, the same
effects of WASF3 knockdown were seen. All of the mice injected
with the control cells formed progressively growing tumors at both
sites after 5 weeks after implantation (Figure 5B). In contrast, in
the mice receiving the WASF3-knockdown cells, although 4 out of
5 mice developed tumors they were significantly smaller than those
seen for WASF3-expressing cells (Figure 5). Western blot data
demonstrated the maintenance of a significant reduction in
WASF3 expression in these tumors (Figure 5). RT–PCR analysis
of cells re-cultured from these DU145/shWASF3 tumor xenografts,
further confirmed the persistent knockdown of WASF3 expression
levels (data not shown).
Down regulation of WASF3 protein reduces metastasis
To investigate whether knockdown of WASF3 could affect
metastasis of prostate cancer cells in vivo, as predicted from
the invasion assays, we subjected selected clones to an experi-
mental metastasis assay. DU145 cells from clone 4 were injected
into the tail veins of three mice. One of these mice died and
was lost to the study, but in the other two, 35 and 47 surface
tumor nodules were counted (Figure 6). Histochemical analysis
demonstrated tumor foci throughout the lungs in both mice
(Figure 6). In contrast, of the four mice injected with cells from
knockdown clone 8, only two showed lung surface tumors.
In these mice there were fewer tumors (11 and 2, respectively),
and they were smaller (Figure 6). The other two mice showed no
tumor nodules. Using a parametric Poisson model to analyse
these data demonstrates a highly significant difference between
the two groups (P¼0.0001). Histopathology analysis of the lungs
from the mice injected with cells with normal expression levels
of WASF3 revealed large tumors throughout the lungs (Figure 6).
In lungs from the mice receiving the WASF3-knockdown cells,
only infrequent, small tumor foci were seen in the mice showing
surface nodules (Figure 6). In the other two mice no tumors
were seen using histochemistry of sections through the lungs.
PC3 cells from clone 31, which showed knockdown of WASF3,
and clone 19 which did not, were similarly injected into the
tail veins of SCID mice. After 12 weeks, the mice were sacrificed
and the lungs removed for analysis. Two animals injected with
clone 19 developed tumors that were clearly visible on the surface
of the lung (data not shown). Histopathological analysis of these
lungs also showed extensive infiltration of the apparently normal
lung in these animals (data not shown). Three other animals that
did not show visible tumors on the lung surface were also
processed for immunohistochemistry analysis and lungs from two
of them revealed microscopic tumor foci in the lungs (Figure 6).
Thus, 80% of the control mice demonstrated metastases. In
contrast, no tumors were identified in the lungs from the mice that
received the clone with WASF3 knockdown on the surface or
following histological analysis (Figure 6). Using a permutation test
there was a significant difference in tumor incidence between the
two groups (P¼0.024).
Loss of WASF3 expression increases stress fibers and focal
adhesions
To understand the role of WASF3 in motility further, we
investigated the reorganization of the cytoskeleton in DU145 cells
carrying stable knockdown of the protein. Immuno-staining of
DU145 parental cells show irregular membrane ruffles or abundant
filopodia and lamellipodia that were typically accompanied by
weak transverse actin stress fiber formation (Figure 6C and D).
Using anti-vinculin antibodies, relatively few focal adhesion
plaques were seen in these cells and were distributed apparently
randomly. In cells showing stable knockdown of WASF3, however,
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sextensive networks of stress fibers were seen and a more organized
radial distribution of focal adhesion plaques were present along
the leading edge of the cells (Figure 6C). Images from other
knockdown clones are shown in Supplementary Figure S1.
Quantitation of these observations showed that B80% of cells
with WASF3 knockdown showed increased plaques and change in
shape compared with B25% of cells showing normal WASF3
expression (Figure 6D).
Loss of WASF3 results in down-regulation of MMPs
As invasion and metastasis are associated with the expression
levels of matrix metalloprotineases (MMP), we analyzed members
of this protein family that have been implicated in prostate cancer
progression. MMP9 showed reduced expression levels in clones
from PC3 and DU145 with knockdown of WASF3, compared
with control cells that did not (Figure 7A). Levels of MMP2 were
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Figure 6 (A, B) Knockdown of WASF3 expression inhibits in vivo metastasis in SCID mice. Pulmonary metastasis of DU145 cells from clone 4
(no knockdown) show multiple surface tumors (a) unlike the knockdown clone 8 that shows vastly reduced numbers (b). Histochemical analysis of lungs
from mice with clone 4 show large tumor foci in both cases (c). In lungs from the mice from clone 8 that developed surface tumors only small tumor foci
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tumor foci in H & E-stained sections (right original magnifications:  200), whereas lungs from mice injected with clone 31 did not show any tumors in
hematoxylin and eosin-stained sections (original magnifications:  50). (C, D) Knockdown of WASF3 expression increases the formation of stress fibers
and focal adhesions in DU145 cells. The localization of F-actin and distribution of vinculin, a structural component of focal adhesions, was examinedb y
indirect immunofluorescence using either an anti-vinculin or Texas-red phalloidin, antibody. In (C) clone 8 cells (original magnifications:  630) show stress
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sunaffected by knockdown of WASF3 (Figure 7A). Analysis of the
pro- and active forms of MMP9 released into the culture medium
demonstrated reduced protein levels compared with the parental
cells and clones with no knockdown of WASF3 (Figure 7B),
consistent with a reduction in mRNA levels.
Re-expression of a siRNA-resistant WASF3 gene rescues
the invasion and stress phenotypes
To discount any potential off-target effects of the WASF3 siRNA
use in these experiments we conducted rescue experiments of
knockdown clones using a siRNA resistant WASF3 cDNA clone.
The shRNAs used throughout this project target the 30UTR of
WASF3. We, therefore, constructed a full-length WASF3 cDNA in
pcDNA3 that lacked the 30UTR and would, therefore, be resistant
to degradation in the WASF3-knockdown cells. This cDNA was
introduced into clone 31 of PC3 cells and Clone 8 of DU145 cells.
As shown in Figure 8A, using PCR primers that specifically amplify
a region within the 30UTR, neither the WASF3-knockdown clones
nor the WASF3-rescued clones showed evidence of the full-length
WASF3. Using primers that amplify a region within the WASF3
open reading frame, the rescued clones show WASF3 expres-
sion. These observations were confirmed by western blotting
(Figure 8B). When these clones were challenged in the matrigel
invasion assay (Figure 8C), the rescued clones showed almost
the same ability as the parental cells to migrate through the
matrix demonstrating recovery from the knockdown phenotype.
When stress fiber formation was assessed in DU145 cells, the
rescue cDNA resulted in a reduction in fibers to levels similar to
those seen in the control cells (Figure 8D, see also Supplementary
Figure S2).
DISCUSSION
Although prostate cancer is a common male malignancy,
with current treatment options relatively few tumors progress to
high-grade tumors in the lifetime of the individual (Lu-Yao et al,
2009). Thus, it is the tumors that are genetically programmed to
progress that represent the major objective for drug targeting.
Identification of genes, which facilitate progression, therefore,
perhaps provides good targets for drug development. In this
report we demonstrate the powerful influence of the WASF3 gene
on prostate cancer cell invasion and metastasis suggesting that
its up-regulation in advanced stage human prostate cancer may
offer a significant target. Because high-level knockdown (490%,
at the protein level) did not affect cell proliferation rates, we
have described WASF3 as an invasion and metastasis promoter,
although the in vivo studies clearly demonstrate that loss of
WASF3 function also affects tumor development. It is possible
that this effect is specific for xenografted tumors from cell
suspensions, as these cells must rapidly reorganize into a tumor
mass that likely requires significant involvement of actin
cytoskeleton dynamics.
The demonstration that WASF3 promotes metastasis in prostate
cancer cells, extends the previous observations for a single breast
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Figure 7 Knockdown of WASF3 expression suppresses MMP9 expression levels and inhibits MMP9 release from prostate cancer cell lines. (A) RT–PCR
analysis of PC3 and DU145 cells showing knockdown of WASF3 also show down-regulation of MMP9, but not MMP2 expression levels. Cont¼parental
cells. (B) Secretion of the pro- and active form of MMP9 from PC3 and DU145 cells were measured in the supernatants of actively growing cells using the
Fluorokine MAP assay procedure. Cells from each clone showing knockdown of WASF3 also showed reduced MMP9 levels compared with parental
(control) and non-knockdown cells that did not.
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scancer cell line, MDA-MB-231 (Sossey-Alaoui et al, 2005a, 2007),
although the lung metastasis assay is less robust for prostate
cancer cells. We noted for parental PC3 cells, for example, that
multiple lung nodules did not develop as seen for MDA-MB-231
cells, suggesting that this may not be an ideal assay for prostate
cancer cell metastasis. Nonetheless, large surface tumors were
seen in two (40%) of the experimental animals and multiple
tumor foci were seen throughout the lungs destroying the
cellular architecture. These animals, however, did not show any
signs of respiratory distress despite the loss of lung tissue.
In another two animals, the tumors were only observed following
histopathological analysis and were relatively small. Significantly,
none of the mice receiving the WASF3-knockdown clones showed
any evidence of metastases on the lung surface or following
histopathological analysis, reinforcing the role of WASF3 in
promoting metastasis.
Degradation of the extracellular matrix by MMP activity is
essential for many normal physiological processes, for example,
during development, cell migration, growth and wound healing
(Rodrı ´guez et al, 2010). On the other hand, increased expression
and activity of MMPs is also associated with tumor invasion,
metastasis and angiogenesis (Basset et al, 1997; Westermarck and
Kahari, 1999; Vincenti and Brinckerhoff, 2002). Expression of most
MMPs is usually low in normal tissues, and induced when
remodeling of the extracellular matrix is required. MMP expres-
sion is primarily regulated at the transcriptional level, although
mRNA stabilization of MMP transcripts in response to growth
factors and cytokines also has a role in the regulation of MMP
activity (Johnsen et al, 1998). In prostate cancer cells, down-
regulation of MMP9, but not MMP2 is consistent with the loss of
the invasion/metastasis phenotype.
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